عرض بسيط للتسجيلة

المؤلفCyprian, Farhan S
المؤلفAkhtar, Saghir
المؤلفGatalica, Zoran
المؤلفVranic, Semir
تاريخ الإتاحة2019-03-28T10:09:22Z
تاريخ النشر2019-03-01
اسم المنشورBosnian Journal of Basic Medical Science
المعرّفhttp://dx.doi.org/10.17305/bjbms.2019.4204
الاقتباسFarhan S. Cyprian, et al. Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer. Bosnian Journal of Basic Medical Science. 2019
الرقم المعياري الدولي للكتاب1512-8601
معرّف المصادر الموحدhttp://hdl.handle.net/10576/11458
الملخصThe treatment of several solid and hematologic malignancies with immune checkpoint inhibitors (against PD-1/PD-L1) has dramatically changed the cancer treatment paradigm. However, no checkpoint inhibitors were previously approved for the treatment of triple-negative breast cancer (TNBC), a difficult-to-treat disease with a high unmet therapeutic need. Based on IMpassion130 clinical trial (NCT02425891), FDA has recently granted an accelerated approval for atezolizumab (TECENTRIQ®), a monoclonal antibody drug targeting PD-L1, plus chemotherapy (Abraxane; nab®-Paclitaxel) for the treatment of adults with PD-L1-positive, unresectable, locally advanced or metastatic TNBC. FDA has also approved the Ventana diagnostic antibody SP142 as a companion test for selecting TNBC patients for treatment with atezolizumab. In the present review, we briefly discuss the importance of this breakthrough as the first cancer immunotherapy regimen to be approved for the management of breast cancer.
اللغةen
الناشرAssociation of Basic Medical Sciences of Federation of Bosnia and Herzegovina
الموضوعbreast cancer
immunotherapy
PD-L1
triple-negative breast cancer
immune checkpoint inhibitors
predictive biomarkers
العنوانTargeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer.
النوعArticle Review
ESSN1840-4812
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة